Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE To enhance the quality of care and clinical outcomes for children and adolescents with major depressive disorder (MDD) and persistent depressive disorder (PDD). The aims are 1) to summarize empirically-based guidance about the psychosocial and psychopharmacologic treatment of MDD and PDD in children and adolescents; and 2) to summarize expert-based guidance about the assessment of these disorders as an integral part of treatment, and the implementation of empirically-based treatments for these disorders in clinical practice. METHOD Statements about the treatment of MDD and PDD are based upon empirical evidence derived from a critical systematic review of the scientific literature conducted by the Research Triangle Institute International - University of North Carolina at Chapel Hill (RTI-UNC) Evidence-based Practice Center under contract with the Agency for Healthcare Research and Quality (AHRQ). Evidence from meta-analyses published since the AHRQ/RTI-UNC review is also presented to support or refute the AHRQ findings. Guidance about the assessment and clinical implementation of treatments for MDD and PDD is informed by expert opinion and consensus as presented in previously published clinical practice guidelines, chapters in leading textbooks of child and adolescent psychiatry, the DSM-5-TR, and government-affiliated prescription drug information websites. RESULTS Psychotherapy (specifically cognitive behavioral and interpersonal therapies) and selective serotonin reuptake inhibitor (SSRI) medication have some rigorous (randomized controlled trials, meta-analyses) empirical support as treatment options. Because effective treatment outcomes are predicated in part upon accuracy of the diagnosis, depth of the clinical formulation, and breadth of the treatment plan, comprehensive, evidence-based assessment may enhance evidence-based treatment outcomes. CONCLUSION Disproportionate to the magnitude of the problem, there are significant limitations in the quality and quantity of rigorous empirical support for the etiology, assessment, and treatment of depression in children and adolescents. In the context of a protracted severe shortage of child and adolescent-trained behavioral health specialists, the demonstration of convenient, efficient, cost-effective, and user-friendly delivery mechanisms for safe and effective treatment of MDD and PDD is a key research need. Other research priorities include the sequencing and comparative effectiveness of depression treatments, delineation of treatment mediators and moderators, effective approaches to treatment non-responders and disorder relapse/recurrence, long-term effects and degree of suicide risk with SSRI use, and the discovery of novel pharmacologic or interventional treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Achenbach, T. M., McConaughy, S. H., & Howell, C. T. (1987) · Psychological Bulletin · doi:10.1037/0033-2909.101.2.213 · Cited by 5,436
Prevalence and development of psychiatric disorders in childhood and adolescence
Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.837 · Cited by 4,035
Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12381 · Cited by 3,990
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“121 According to a recent systematic review, measurement-based treatment occurred primarily in outpatient mental health settings; around one-third of programs had provider-only assessments, and one-half had both provider and self-assessments.”
BackgroundToward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053 · cited 1×
“48 In sum, the overdetermined nature of depressive disorders, especially in children and adolescents, creates substantial diagnostic, formulation, and treatment challenges for the clinician and methodologic challenges for the researcher.”
BackgroundGreen, J. G., McLaughlin, K. A., Berglund, P. A., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.186 · Cited by 2,323
National trends in the prevalence and treatment of depression in adolescents and young adults.
Mojtabai, R., Olfson, M., & Han, B. (2016) · Pediatrics · doi:10.1542/peds.2016-1878 · Cited by 1,424
Poverty, depression, and anxiety: Causal evidence and mechanisms
Ridley, M., Rao, G., Schilbach, F., & Patel, V. (2020) · Science · doi:10.1126/science.aay0214 · Cited by 1,220
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056 · cited 2×
“Nonetheless, congruent with national and international guidelines, 8,60-62 in this guideline psychotherapy (speci fi cally CBT and inter-personal therapy) and psychopharmacology (speci fi cally selective serotonin reuptake inhibitor [SSRI] medication [except paroxetine]) have some rigorous…”
BackgroundMethodLearned helplessness at fifty: Insights from neuroscience.
Maier, S. F., & Seligman, M. E. P. (2016) · Psychological Review · doi:10.1037/rev0000033 · Cited by 1,031
Depression: A cognitive perspective
LeMoult, J., & Gotlib, I. H. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.008 · Cited by 792
The neurobiology of depression: An integrated view
Dean, J., & Keshavan, M. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.025 · Cited by 765 · cited 1×
“13 The serotonin transporter gene; 14 variations in cerebral structure and function; 15 and neuroendocrine, 16 neuroin fl ammatory, 17 neurochemical, 18 autonomic, 19 chronobiologic, 20 and gut microbiome 21 systems as well as interactions among these, 22 have been implicated.”
BackgroundBrent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753
Implementing Measurement-Based Care in Behavioral Health: A Review
Lewis, C. C., Boyd, M., Puspitasari, A., Navarro, E., Howard, J., Kassab, H., Hoffman, M., Scott, K., Lyon, A., Douglas, S., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3329 · Cited by 605
Efficacy of interpersonal psychotherapy for depressed adolescents
Mufson, L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.573 · Cited by 552
Interpersonal Processes in Depression
Hames, J. L., Hagan, C. R., & Joiner, T. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185553 · Cited by 499
Differences in Early Childhood Risk Factors for Juvenile-Onset and Adult-Onset Depression
Jaffee, S. R., Moffitt, T. E., Caspi, A., Fombonne, E., Poulton, R., & Martin, J. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.215 · Cited by 472 · cited 1×
“34,41 In longitudinal studies, 42-44 the onset of MDD in youth has been characterized by a complex pattern of exposure to adverse childhood circumstances and concurrent psychiatric comorbidity (anxiety, behavior, and attention disorders).”
BackgroundNarrow, W. E., Clarke, D. E., Kuramoto, S. J., Kraemer, H. C., Kupfer, D. J., Greiner, L., & Regier, D. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12071000 · Cited by 446 · cited 2×
“98 These instruments could be included in intake packets to systematically and ef fi ciently gather information about presenting problems remotely, prior to the evaluation.”
BackgroundPsychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis
Cuijpers, P., Karyotaki, E., Eckshtain, D., Ng, M. Y., Corteselli, K. A., Noma, H., Quero, S., & Weisz, J. R. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0164 · Cited by 429
Evaluation of the PHQ-2 as a Brief Screen for Detecting Major Depression Among Adolescents
Richardson, L. P., Rockhill, C., Russo, J. E., Grossman, D. C., Richards, J., McCarty, C., McCauley, E., & Katon, W. (2010) · Pediatrics · doi:10.1542/peds.2009-2712 · Cited by 377
Self-citationBurleson Daviss, W., Birmaher, B., Melhem, N. A., Axelson, D. A., Michaels, S. M., & Brent, D. A. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01646.x · Cited by 370
Zhou, X., Teng, T., Zhang, Y., Del Giovane, C., Furukawa, T. A., Weisz, J. R., Li, X., Cuijpers, P., Coghill, D., Xiang, Y., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30137-1 · Cited by 367
Sharp, C., Goodyer, I. M., & Croudace, T. J. (2006) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-006-9027-x · Cited by 358
Goodyer, I., Dubicka, B., Wilkinson, P., Kelvin, R., Roberts, C., Byford, S., Breen, S., Ford, C., Barrett, B., Leech, A., et al. (2007) · BMJ · doi:10.1136/bmj.39224.494340.55 · Cited by 352 · cited 3×
“Although the 2 studies noted above 52,156 demonstrated bene fi t for combination treatment (CBT þ fl uoxetine), this fi nding was inconsistent with a British RCT (excluded from the AHRQ/RTI-UNC review because of ineligible population) that failed to fi nd bene fi t of combination treatment ( fl uoxetine þ CBT) over mono-the…”
MethodInfluentialAssociations of Childhood and Adolescent Depression With Adult Psychiatric and Functional Outcomes
Copeland, W. E., Alaie, I., Jonsson, U., & Shanahan, L. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.07.895 · Cited by 310 · cited 1×
“34,41 In longitudinal studies, 42-44 the onset of MDD in youth has been characterized by a complex pattern of exposure to adverse childhood circumstances and concurrent psychiatric comorbidity (anxiety, behavior, and attention disorders).”
BackgroundSpruit, A., Goos, L., Weenink, N., Rodenburg, R., Niemeyer, H., Stams, G. J., & Colonnesi, C. (2020) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-019-00299-9 · Cited by 280
Grading the strength of a body of evidence when assessing health care interventions: an EPC update
Berkman, N. D., Lohr, K. N., Ansari, M. T., Balk, E. M., Kane, R., McDonagh, M., Morton, S. C., Viswanathan, M., Bass, E. B., Butler, M., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.023 · Cited by 279
Goodyer, I. M., Reynolds, S., Barrett, B., Byford, S., Dubicka, B., Hill, J., Holland, F., Kelvin, R., Midgley, N., Roberts, C., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30378-9 · Cited by 259
Ribeiro, W. S., Bauer, A., Andrade, M. C. R., York-Smith, M., Pan, P. M., Pingani, L., Knapp, M., Coutinho, E. S. F., & Evans-Lacko, S. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30159-1 · Cited by 240 · cited 1×
“…circumstances in the family (particularly emotional abuse 34 and unattuned/unsupportive parenting styles [eg, passive/ withdrawn or discordant 35 ]), to societal issues such as poverty, 36 income inequality, 37 racial/ethnic 38 and other forms of discrimination, 39 and acculturation stress.”
BackgroundMeta-analysis: 13-year follow-up of psychotherapy effects on youth depression
Eckshtain, D., Kuppens, S., Ugueto, A., Ng, M. Y., Vaughn-Coaxum, R., Corteselli, K., & Weisz, J. R. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.04.002 · Cited by 224
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., Asarnow, J. R., Spirito, A., Birmaher, B., Ryan, N., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09040552 · Cited by 217
Antidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214 · cited 1×
“181 Accordingly, these medications warrant close adherence to the prescribed regimen and a slow discontinuation taper.”
BackgroundEmslie, G. J., Ventura, D., Korotzer, A., & Tourkodimitris, S. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181a2b304 · Cited by 210 · cited 1×
“…were included in the AHRQ/RTI-UNC review (see the review for study summaries 51 ), including 14 RCTs of selective serotonin reuptake inhibitors (SSRIs) with 8 RCTs of fl uoxetine, 151-160 and one RCT of escitalopram, 161,162 and the remaining RCTs of citalopram, vilazodone, and paroxetine.”
MethodValidity of the Short Mood and Feelings Questionnaire in late adolescence
Turner, N., Joinson, C., Peters, T. J., Wiles, N., & Lewis, G. (2014) · Psychological Assessment · doi:10.1037/a0036572 · Cited by 198
Kennard, B. D., Emslie, G. J., Mayes, T. L., Nakonezny, P. A., Jones, J. M., Foxwell, A. A., & King, J. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13111460 · Cited by 134
Murphy, S. E., Capitão, L. P., Giles, S. L. C., Cowen, P. J., Stringaris, A., & Harmer, C. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00154-1 · Cited by 112
Cuijpers, P., Pineda, B. S., Ng, M. Y., Weisz, J. R., Muñoz, R. F., Gentili, C., Quero, S., & Karyotaki, E. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.11.024 · Cited by 102 · cited 1×
“86 In primary care, school, or other child-serving settings, psychometrically sound and freely available general social (cid:1) emotional screening instruments (eg, Pediatric Symptom Checklist [https://www.massgeneral.org/ psychiatry/treatments-and-services/pediatric-symptom-checklist], 87…”
BackgroundBear, H. A., Edbrooke-Childs, J., Norton, S., Krause, K. R., & Wolpert, M. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.12.002 · Cited by 101
Kennard, B. D., Emslie, G. J., Mayes, T. L., Nightingale-Teresi, J., Nakonezny, P. A., Hughes, J. L., Jones, J. M., Tao, R., Stewart, S. M., & Jarrett, R. B. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31818914a1 · Cited by 98
Hopkins, K., Crosland, P., Elliott, N., Bewley, S., & On behalf of the Clinical Guidelines Update Committee B (2015) · BMJ · doi:10.1136/bmj.h824 · Cited by 85
Antidepressants and Psychostimulants in Pediatric Populations: Is there an Association with Mania?
Goldsmith, M., Singh, M., & Chang, K. (2011) · Pediatric Drugs · doi:10.2165/11591660-000000000-00000 · Cited by 79
Dietz, L. J., Weinberg, R. J., Brent, D. A., & Mufson, L. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.12.011 · Cited by 74
Findling, R. L., Robb, A., & Bose, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0023 · Cited by 57 · cited 1×
“…were included in the AHRQ/RTI-UNC review (see the review for study summaries 51 ), including 14 RCTs of selective serotonin reuptake inhibitors (SSRIs) with 8 RCTs of fl uoxetine, 151-160 and one RCT of escitalopram, 161,162 and the remaining RCTs of citalopram, vilazodone, and paroxetine.”
Method
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Santomauro, D. F., Vos, T., Whiteford, H. A., Chisholm, D., Saxena, S., & Ferrari, A. J. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00317-1 · Cited by 57
Eserian, J. K., Blanco, V. P., Mercuri, L. P., Matos, J. D. R., & Galduróz, J. C. F. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115537 · Cited by 15
Metadata
- Authors
- Walter, H. J., Abright, A. R., Bukstein, O. G., Diamond, J., Keable, H., Ripperger-Suhler, J., & Rockhill, C.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 62
- Issue
- 5
- Pages
- 479-502
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W4306967089
- Cited by
- 193
- References
- 47
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.